The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Increased Iron and Free Radical Generation in Preclinical Alzheimer Disease and Mild Cognitive Impairment
Open accessAbstract
It is now established that oxidative stress is one of the earliest, if not the earliest, change that occurs in the pathogenesis of Alzheimer's disease (AD). Consistent with this, mild cognitive impairment (MCI), the clinical precursor of AD, is also characterized by elevations in oxidative stress. Since such stress does not operate in vacuo, in this study we sought to determine whether redox-active iron, a potent source of free radicals, was elevated in MCI and preclinical AD as compared to cognitively-intact age-matched control patients. Increased iron was found at the highest levels both in the cortex and cerebellum from the pre-clinical AD/MCI cases. Interestingly, glial accumulations of redox-active iron in the cerebellum were also evident in preclinical AD patients and tended to increase as patients became progressively cognitively impaired. Our findings suggests that an imbalance in iron homeostasis is a precursor to the neurodegenerative processes leading to AD and that iron imbalance is not necessarily unique to affected regions. In fact, an understanding of iron deposition in other regions of the brain may provide insights into neuroprotective strategies. Iron deposition at the preclinical stage of AD may be useful as a diagnostic tool, using iron imaging methods, as well as a potential therapeutic target, through metal ion chelators.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Clinical Dementia Rating (CDR): Current version and scoring rules
Morris, J. C. (1993) · Neurology · doi:10.1212/wnl.43.11.2412-a · Cited by 9,882
Copper, iron and zinc in Alzheimer's disease senile plaques
Lovell, M. A., Robertson, J. D., Teesdale, W. J., Campbell, J. L., & Markesbery, W. R. (1998) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00092-6 · Cited by 2,120
Oxidative Damage Is the Earliest Event in Alzheimer Disease
Nunomura, A., Perry, G., Aliev, G., Hirai, K., Takeda, A., Balraj, E. K., Jones, P. K., Ghanbari, H., Wataya, T., Shimohama, S., et al. (2001) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/60.8.759 · Cited by 1,885
Self-citationMitochondrial abnormalities in Alzheimer's disease
Hirai, K., Aliev, G., Nunomura, A., Fujioka, H., Russell, R. L., Atwood, C. S., Johnson, A. B., Kress, Y., Vinters, H. V., Tabaton, M., et al. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-09-03017.2001 · Cited by 1,367
Self-citationReiman, E. M., Caselli, R. J., Yun, L. S., Chen, K., Bandy, D., Minoshima, S., Thibodeau, S. N., & Osborne, D. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603213341202 · Cited by 1,366
Iron accumulation in Alzheimer disease is a source of redox-generated free radicals
Smith, M. A., Harris, P. L. R., Sayre, L. M., & Perry, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.18.9866 · Cited by 1,355
Self-citationSayre, L. M., Zelasko, D. A., Harris, P. L. R., Perry, G., Salomon, R. G., & Smith, M. A. (1997) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1997.68052092.x · Cited by 1,007
Self-citationSynaptic Targeting by Alzheimer's-Related Amyloid β Oligomers
Lacor, P. N., Buniel, M. C., Chang, L., Fernandez, S. J., Gong, Y., Viola, K. L., Lambert, M. P., Velasco, P. T., Bigio, E. H., Finch, C. E., et al. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3432-04.2004 · Cited by 954
Wang, X., Su, B., Siedlak, S. L., Moreira, P. I., Fujioka, H., Wang, Y., Casadesus, G., & Zhu, X. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0804871105 · Cited by 835
Self-citationRNA Oxidation Is a Prominent Feature of Vulnerable Neurons in Alzheimer’s Disease
Nunomura, A., Perry, G., Pappolla, M. A., Wade, R., Hirai, K., Chiba, S., & Smith, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01959.1999 · Cited by 722
Self-citationChemistry and Biochemistry of Oxidative Stress in Neurodegenerative Disease
Sayre, L., Smith, M., & Perry, G. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372922 · Cited by 607
Self-citationPlasma antioxidants are similarly depleted in mild cognitive impairment and in Alzheimer’s disease
Rinaldi, P., Polidori, M. C., Metastasio, A., Mariani, E., Mattioli, P., Cherubini, A., Catani, M., Cecchetti, R., Senin, U., & Mecocci, P. (2003) · Neurobiology of Aging · doi:10.1016/s0197-4580(03)00031-9 · Cited by 549
Sayre, L. M., Perry, G., Harris, P. L. R., Liu, Y., Schubert, K. A., & Smith, M. A. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0740270.x · Cited by 540
Self-citationEvidence of increased oxidative damage in subjects with mild cognitive impairment
Keller, J. N., Schmitt, F. A., Scheff, S. W., Ding, Q., Chen, Q., Butterfield, D. A., & Markesbery, W. R. (2005) · Neurology · doi:10.1212/01.wnl.0000156156.13641.ba · Cited by 539
Alzheimer's disease: The amyloid cascade hypothesis: An update and reappraisal
Hardy, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s317 · Cited by 475
Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
McShea, A., Harris, P. L. R., Webster, K. R., Wahl, A. F., & Smith, M. A. (1997) · Europe PMC (PubMed Central) · Cited by 468
Self-citationAlzheimer's disease: the two-hit hypothesis
Zhu, X., Raina, A. K., Perry, G., & Smith, M. A. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00707-0 · Cited by 426
Self-citationHeme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer's disease.
Smith, M. A., Kutty, R. K., Richey, P. L., Yan, S. D., Stern, D., Chader, G. J., Wiggert, B. O., Petersen, R. B., & Perry, G. L. (1994) · PubMed · Cited by 424
Self-citationYan, S. D., Yan, S. F., Chen, X., Fu, J., Chen, M., Kuppusamy, P., Smith, M. A., Perry, G., Godman, G. C., Nawroth, P., et al. (1995) · Nature Medicine · doi:10.1038/nm0795-693 · Cited by 406
Self-citationCuajungco, M. P., Goldstein, L. E., Nunomura, A., Smith, M. A., Lim, J. T., Atwood, C. S., Huang, X., Farrag, Y. W., Perry, G., & Bush, A. I. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.c000165200 · Cited by 391
Self-citationMartins, I. J., Hone, E., Foster, J. K., Sünram-Lea, S. I., Gnjec, A., Fuller, S. J., Nolan, D., Gandy, S. E., & Martins, R. N. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001854 · Cited by 388
Oxidative stress increases expression and activity of BACE in NT2 neurons
Tamagno, E., Bardini, P., Obbili, A., Vitali, A., Borghi, R., Zaccheo, D., Pronzato, M. A., Danni, O., Smith, M. A., Perry, G., et al. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2002.0515 · Cited by 385
Self-citationRedox-active iron mediates amyloid-β toxicity
Rottkamp, C. A., Raina, A. K., Zhu, X., Gaier, E., Bush, A. I., Atwood, C. S., Chevion, M., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(00)00494-9 · Cited by 375
Self-citationConnor, J. R., Snyder, B. S., Beard, J. L., Fine, R. E., & Mufson, E. J. (1992) · Journal of Neuroscience Research · doi:10.1002/jnr.490310214 · Cited by 374
Expression of heme oxygenase‐1 in the senescent and alzheimer‐diseased brain
Schipper, H. M., Cissé, S., & Stopa, E. G. (1995) · Annals of Neurology · doi:10.1002/ana.410370609 · Cited by 356
Wang, X., Su, B., Fujioka, H., & Zhu, X. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.071208 · Cited by 341
Self-citationTamagno, E., Guglielmotto, M., Aragno, M., Borghi, R., Autelli, R., Giliberto, L., Muraca, G., Danni, O., Zhu, X., Smith, M. A., et al. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05072.x · Cited by 338
Self-citationMicrotubule Reduction in Alzheimer's Disease and Aging Is Independent of τ Filament Formation
Cash, A. D., Aliev, G., Siedlak, S. L., Nunomura, A., Fujioka, H., Zhu, X., Raina, A. K., Vinters, H. V., Tabaton, M., Johnson, A. B., et al. (2003) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)64296-4 · Cited by 307
Self-citationPerry, G., Nunomura, A., Hirai, K., Zhu, X., Prez, M., Avila, J., Castellani, R. J., Atwood, C. S., Aliev, G., Sayre, L. M., et al. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01113-9 · Cited by 297
Self-citationAlzheimer disease, the two-hit hypothesis: An update
Zhu, X., Lee, H.-G., Perry, G., & Smith, M. A. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.10.014 · Cited by 292
Self-citationAre mitochondria critical in the pathogenesis of Alzheimer's disease?
Reddy, P. H., & Beal, M. F. (2005) · Brain Research Reviews · doi:10.1016/j.brainresrev.2005.03.004 · Cited by 289
Drug Development Based on the Metals Hypothesis of Alzheimer's Disease
Bush, A. I. (2008) · Journal of Alzheimer's Disease · doi:10.3233/jad-2008-15208 · Cited by 267
Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients
Migliore, L., Fontana, I., Trippi, F., Colognato, R., Coppedè, F., Tognoni, G., Nucciarone, B., & Siciliano, G. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.07.016 · Cited by 263
Increased oxidative damage in nuclear and mitochondrial DNA in mild cognitive impairment
Wang, J., Markesbery, W. R., & Lovell, M. A. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03615.x · Cited by 260
Oxidative damage in mild cognitive impairment and early Alzheimer's disease
Lovell, M. A., & Markesbery, W. R. (2007) · Journal of Neuroscience Research · doi:10.1002/jnr.21346 · Cited by 245
Guglielmotto, M., Aragno, M., Autelli, R., Giliberto, L., Novo, E., Colombatto, S., Danni, O., Parola, M., Smith, M. A., Perry, G., et al. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05858.x · Cited by 243
Self-citationTau phosphorylation in Alzheimer's disease: pathogen or protector?
Lee, H.-G., Perry, G., Moreira, P. I., Garrett, M. R., Liu, Q., Zhu, X., Takeda, A., Nunomura, A., & Smith, M. A. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.02.008 · Cited by 243
Self-citationLymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease
Mecocci, P. (2002) · Archives of Neurology · doi:10.1001/archneur.59.5.794 · Cited by 229
Smith, M. A., Rudnicka‐Nawrot, M., Richey, P. L., Praprotnik, D., Mulvihill, P., Miller, C. A., Sayre, L. M., & Perry, G. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.64062660.x · Cited by 225
Self-citationSmith, M. A., Sayre, L. M., Anderson, V. E., Harris, P. L. R., Beal, M. F., Kowall, N., & Perry, G. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600605 · Cited by 222
Self-citationPremkumar, D. R. D., Smith, M. A., Richey, P. L., Petersen, R. B., Castellani, R., Kutty, R. K., Wiggert, B., Perry, G., & Kalaria, R. N. (1995) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1995.65031399.x · Cited by 211
Self-citationGlial heme oxygenase-1 expression in Alzheimer disease and mild cognitive impairment
SCHIPPER, H., BENNETT, D., LIBERMAN, A., BIENIAS, J., SCHNEIDER, J., KELLY, J., & ARVANITAKIS, Z. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.01.016 · Cited by 199
Castellani, R. J., Harris, P. L. R., Sayre, L. M., Fujii, J., Taniguchi, N., Vitek, M. P., Founds, H., Atwood, C. S., Perry, G., & Smith, M. A. (2001) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(01)00570-6 · Cited by 198
Self-citationMoreira, P. I., Harris, P. L. R., Zhu, X., Santos, M. S., Oliveira, C. R., Smith, M. A., & Perry, G. (2007) · Journal of Alzheimer's Disease · doi:10.3233/jad-2007-12210 · Cited by 196
Self-citationAmyloid-β and τ serve antioxidant functions in the aging and Alzheimer brain
Smith, M. A., Casadesus, G., Joseph, J. A., & Perry, G. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)01021-3 · Cited by 189
Self-citationThree Histidine Residues of Amyloid-β Peptide Control the Redox Activity of Copper and Iron
Nakamura, M., Shishido, N., Nunomura, A., Smith, M. A., Perry, G., Hayashi, Y., Nakayama, K., & Hayashi, T. (2007) · Biochemistry · doi:10.1021/bi701079z · Cited by 182
Self-citationIron: The Redox-active Center of Oxidative Stress in Alzheimer Disease
Castellani, R. J., Moreira, P. I., Liu, G., Dobson, J., Perry, G., Smith, M. A., & Zhu, X. (2007) · Neurochemical Research · doi:10.1007/s11064-007-9360-7 · Cited by 180
Self-citationLiu, G., Men, P., Harris, P. L. R., Rolston, R. K., Perry, G., & Smith, M. A. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.07.020 · Cited by 178
Self-citationAbnormal localization of iron regulatory protein in Alzheimer’s disease
Smith, M. A., Wehr, K., Harris, P. L. R., Siedlak, S. L., Connor, J. R., & Perry, G. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00002-x · Cited by 162
Self-citationNanoparticle and other metal chelation therapeutics in Alzheimer disease
Liu, G., Garrett, M. R., Men, P., Zhu, X., Perry, G., & Smith, M. A. (2005) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2005.06.006 · Cited by 158
Self-citationAutophagocytosis of Mitochondria Is Prominent in Alzheimer Disease
Moreira, P. I., Siedlak, S. L., Wang, X., Santos, M. S., Oliveira, C. R., Tabaton, M., Nunomura, A., Szweda, L. I., Aliev, G., Smith, M. A., et al. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000240476.73532.b0 · Cited by 157
Self-citationRe-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease
McShea, A., Wahl, A. F., & Smith, M. A. (1999) · Medical Hypotheses · doi:10.1054/mehy.1997.0680 · Cited by 151
Self-citationAbsence of cognitive impairment or decline in preclinical Alzheimer’s disease
Goldman, W. P., Price, J. L., Storandt, M., Grant, E., McKeel, D. W., Rubin, E. H., & Morris, J. C. (2001) · Neurology · doi:10.1212/wnl.56.3.361 · Cited by 150
Self-citationDietary Links to Alzheimer's Disease: 1999 Update
Grant, W. B. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-501 · Cited by 150
Liu, G., Men, P., Kudo, W., Perry, G., & Smith, M. A. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.03.064 · Cited by 148
Self-citationNeuropathology of Alzheimer disease: pathognomonic but not pathogenic
Castellani, R. J., Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0071-y · Cited by 141
Self-citationButterfield, D. A., & Rukhsana Sultana, A. (2007) · Journal of Alzheimer s Disease · doi:10.3233/jad-2007-12107 · Cited by 136
Amit, T., Avramovich‐Tirosh, Y., Youdim, M. B. H., & Mandel, S. (2008) · The FASEB Journal · doi:10.1096/fj.07-8627rev · Cited by 126
Russell, R. L., Siedlak, S. L., Raina, A. K., Bautista, J. M., Smith, M. A., & Perry, G. L. (1999) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1999.1404 · Cited by 126
Self-citationThe cerebellum in mild cognitive impairment and Alzheimer’s disease – A structural MRI study
Thomann, P. A., Schläfer, C., Seidl, U., Santos, V. D., Essig, M., & Schröder, J. (2008) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2007.12.002 · Cited by 125
Oxidative damage in Alzheimer's disease: the metabolic dimension
Perry, G. L., Nunomura, A., Hirai, K., Takeda, A., Aliev, G., & Smith, M. A. (2000) · International Journal of Developmental Neuroscience · doi:10.1016/s0736-5748(00)00006-x · Cited by 120
Self-citationEarly Glycoxidation Damage in Brains from Down's Syndrome
Odetti, P. R., Angelini, G., Dapino, D., Zaccheo, D., Garibaldi, S., Dagna-Bricarelli, F., Piombo, G., Perry, G. L., Smith, M. A., Traverso, N., et al. (1998) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.8186 · Cited by 118
Self-citationCell cycle proteins in Alzheimer's disease: Plenty of wheels but no cycle
Bowser, R. P., & Smith, M. A. (2002) · Journal of Alzheimer s Disease · doi:10.3233/jad-2002-4316 · Cited by 99
Self-citationAmyloid Beta: The Alternate Hypothesis
Lee, H., Zhu, X., Nunomura, A., Perry, G. L., & Smith, M. A. (2006) · Current Alzheimer Research · doi:10.2174/156720506775697124 · Cited by 96
Self-citationOxidative damage in cultured human olfactory neurons from Alzheimer's disease patients
Ghanbari, H. A., Ghanbari, K., Harris, P. L. R., Jones, P. K., Kubat, Z., Castellani, R. J., Wolozin, B. L., Smith, M. A., & Perry, G. L. (2004) · Aging Cell · doi:10.1111/j.1474-9728.2004.00083.x · Cited by 89
Self-citationLipid peroxidation and 4-hydroxy-2-nonenal formation by copper ion bound to amyloid-β peptide
Hayashi, T., Shishido, N., Nakayama, K., Nunomura, A., Smith, M. A., Perry, G. L., & Nakamura, M. (2007) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2007.08.013 · Cited by 84
Self-citationChronic antioxidant therapy reduces oxidative stress in a mouse model of Alzheimer's disease
Siedlak, S. L., Casadesús, G., Webber, K. M., Pappolla, M. A., Atwood, C., Smith, M. A., & Perry, G. L. (2009) · Free Radical Research · doi:10.1080/10715760802644694 · Cited by 82
Self-citationAntioxidant protection and neurodegenerative disease: The role of amyloid-β and tau
Castellani, R. J., Lee, H., Perry, G. L., & Smith, M. A. (2006) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/153331750602100213 · Cited by 80
Self-citationOxidative stress in mild cognitive impairment and Alzheimer disease: A continuum
Mecocci, P. (2004) · Journal of Alzheimer s Disease · doi:10.3233/jad-2004-6207 · Cited by 79
Diet and Oxidative Stress: A Novel Synthesis of Epidemiological Data on Alzheimer's Disease
Smith, M. A., Petot, G. J., & Perry, G. L. (1999) · Journal of Alzheimer s Disease · doi:10.3233/jad-1999-14-502 · Cited by 77
Self-citationSmith, M. A., re, L. M. S., Vitek, M. P., Monnier, V. M., & Perry, G. L. (1995) · Nature · doi:10.1038/374316b0 · Cited by 73
Self-citationMild Cognitive Impairment and Alzheimer Patients Display Different Levels of Redox-Active CSF Iron
Manuel Lavados, M., Guillón, M., Mujica, M. C., Rojo, L. E., Fuentes, P., & Maccioni, R. B. (2008) · Journal of Alzheimer s Disease · doi:10.3233/jad-2008-13211 · Cited by 61
Mattson, M. P., Carney, J. M., & Butterfield, D. A. (1995) · Nature · doi:10.1038/373481a0 · Cited by 60
A Metabolic Basis for Alzheimer Disease
Perry, G. L., Nunomura, A., Raina, A. K., Aliev, G., Siedlak, S. L., Harris, P. L. R., Casadesús, G., Petersen, R. B., Bligh-Glover, W. Z., Balraj, E. K., et al. (2003) · Neurochemical Research · doi:10.1023/a:1025678510480 · Cited by 55
Self-citationProgress from Alzheimer's tangles to pathological tau points towards more effective therapies now
Lee, V. M. ‐., & Trojanowski, J. Q. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s328 · Cited by 55
Oxidative stress and iron imbalance in Alzheimer disease: How rust became the fuss!
Smith, M. A. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s334 · Cited by 45
Self-citationNeuronal Death versus Synaptic Pathology in Alzheimer's Disease
Bertoni–Freddari, C., Fattoretti, P., Solazzi, M., Giorgetti, B., Stefano, G. D., Casoli, T., & Meier-Ruge, W. A. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1299.116 · Cited by 30
Brain Samples from Alzheimer's Patients Have Elevated Levels of Loosely Bound Iron
Kala, S. V., Hasinoff, B. B., & Richardson, J. S. (1996) · International Journal of Neuroscience · doi:10.3109/00207459608986717 · Cited by 29
Blass, J. P., Sheu, K. R., Piacentini, S., & Sorbi, S. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48488.x · Cited by 27
Tau protein, the main component of paired helical filaments
Ávila, J. (2006) · Journal of Alzheimer s Disease · doi:10.3233/jad-2006-9s320 · Cited by 25
Neuroimaging and genetic assessment for early diagnosis of Alzheimer's disease.
Gw, S. (1996) · PubMed · Cited by 22
Oxidative stress and lymphocytes in Alzheimer disease
Mecocci, P., Cherubini, A., Polidori, M. C., Cecchetti, R., Chionne, F., & Senin, U. (1998) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(98)80044-7 · Cited by 3
Price (1999) · doi:10.1002/1531-8249(199903)45:3
Cited by
The development of the concept of ferroptosis
Hirschhorn, T., & Stockwell, B. R. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2018.09.043 · Cited by 1,052
Oxidative Stress in Neurodegenerative Diseases: From Molecular Mechanisms to Clinical Applications
Liu, Z., Zhou, T., Ziegler, A. C., Dimitrion, P., & Zuo, L. (2017) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2017/2525967 · Cited by 810
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672
Basic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Iron neurochemistry in Alzheimer's disease and Parkinson's disease: targets for therapeutics
Belaidi, A. A., & Bush, A. I. (2016) · Journal of Neurochemistry · doi:10.1111/jnc.13425 · Cited by 578
Metadata
- Authors
- Smith, M. A., Zhu, X., Tabaton, M., Liu, G., McKeel, D. W., Cohen, M. L., Wang, X., Siedlak, S. L., Dwyer, B. E., Hayashi, T., Nakamura, M., Nunomura, A., & Perry, G.
- Venue
- Journal of Alzheimer's Disease
- Publisher
- SAGE Publications
- Published
- 2010-01-06
- Volume
- 19
- Issue
- 1
- Pages
- 363-372
- ISSN
- 1387-2877 (ISSN-L)
- 1875-8908
- OpenAlex
- W2110464595
- Cited by
- 401
- References
- 83
- FWCI
- 25.49
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.